We believe that an increase in serum fetuin-B levels in patients with MetS can be attributed to elevated metabolic stress, involving, for example, hyperinsulinemia, dyslipidosis, and antioxidative disorder. This evidence concerns the gene FETUB and hyperinsulinism.